1. Shan, Jijun, Jiang, Wangjie, Chang, Jiang, Li, Changxian, Li, Xiangcheng. 2023. NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1. In International journal of biological sciences, 19, 1336-1351. doi:10.7150/ijbs.80737. https://pubmed.ncbi.nlm.nih.gov/37056930/
2. Jiang, Feng, Huang, Xiaolu, Yang, Xiang, Zhou, Huixin, Wang, Yumin. 2022. NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis. In Frontiers in oncology, 12, 795971. doi:10.3389/fonc.2022.795971. https://pubmed.ncbi.nlm.nih.gov/35814368/
3. Long, Bo, Zhou, Huinian, Xiao, Lixia, Yu, Zeyuan, Jiao, Zuoyi. 2024. Targeting NUF2 suppresses gastric cancer progression through G2/M phase arrest and apoptosis induction. In Chinese medical journal, 137, 2437-2451. doi:10.1097/CM9.0000000000003006. https://pubmed.ncbi.nlm.nih.gov/39193700/
4. Bao, Lisha, Gong, Yingying, Che, Yulu, Pan, Zongfu, Ge, Minghua. 2024. Maintenance of magnesium homeostasis by NUF2 promotes protein synthesis and anaplastic thyroid cancer progression. In Cell death & disease, 15, 656. doi:10.1038/s41419-024-07041-6. https://pubmed.ncbi.nlm.nih.gov/39242581/
5. Ren, Meng, Zhao, Hongyu, Gao, Yan, Zhao, Xiaoting, Yue, Wentao. 2023. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer. In Journal of ovarian research, 16, 17. doi:10.1186/s13048-023-01101-9. https://pubmed.ncbi.nlm.nih.gov/36670423/
6. Jiang, Xiaodan, Jiang, Yan, Luo, Senbiao, Wang, Yu, Hui, Kam Man. 2020. Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers. In Cancer research and treatment, 53, 944-961. doi:10.4143/crt.2020.466. https://pubmed.ncbi.nlm.nih.gov/33421974/
7. Sun, Jingbo, Chen, Jiawei, Wang, Zhizhi, Liu, Lixin, Liu, Xiaolong. . [Expression of NUF2 in breast cancer and its clinical significance]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 39, 591-597. doi:10.12122/j.issn.1673-4254.2019.05.15. https://pubmed.ncbi.nlm.nih.gov/31140425/
8. Leng, Ruobing, Meng, Yunfang, Sun, Xiaomei, Zhao, Yingzi. 2022. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes. In Frontiers in oncology, 12, 1057198. doi:10.3389/fonc.2022.1057198. https://pubmed.ncbi.nlm.nih.gov/36620547/